Jinxin Technology Holding Company American Depositary Shares' (NASDAQ:NAMI - Get Free Report) lock-up period is set to end on Wednesday, June 4th. Jinxin Technology Holding Company American Depositary Shares had issued 1,250,000 shares in its initial public offering on December 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. After the expiration of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen upgraded shares of Jinxin Technology Holding Company American Depositary Shares from a "hold" rating to a "buy" rating in a report on Saturday.
Check Out Our Latest Analysis on NAMI
Jinxin Technology Holding Company American Depositary Shares Stock Performance
Shares of NAMI stock traded down $0.18 during trading hours on Friday, hitting $1.15. 584,154 shares of the company's stock traded hands, compared to its average volume of 141,043. The stock has a fifty day moving average price of $2.92. Jinxin Technology Holding Company American Depositary Shares has a 12-month low of $1.11 and a 12-month high of $7.75.
Hedge Funds Weigh In On Jinxin Technology Holding Company American Depositary Shares
A hedge fund recently bought a new stake in Jinxin Technology Holding Company American Depositary Shares stock. XTX Topco Ltd bought a new stake in shares of Jinxin Technology Holding Company American Depositary Shares (NASDAQ:NAMI - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 26,778 shares of the company's stock, valued at approximately $75,000.
About Jinxin Technology Holding Company American Depositary Shares
(
Get Free Report)
Jinxin Technology Holding Co engages in the provision of digital content services. The company was founded in August 2015 and is headquartered in Shanghai, China.
Featured Articles
Before you consider NAMI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NAMI wasn't on the list.
While NAMI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.